Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients.
Vrij C, Bogaerts K, Vermeersch P, Lagrou K, Molenberghs G, Rega F, Ceulemans LJ, Van Raemdonck D, Jochmans I, Monbaliu D, Pirenne J, Robaeys G, De Moor B, Vanuytsel T, Gillard P, Schoemans H, Van Cleemput J, Kuypers D, Vos R, Nevens F, Verbeek J. Vrij C, et al. Among authors: vanuytsel t. Sci Rep. 2024 Nov 2;14(1):26465. doi: 10.1038/s41598-024-78119-6. Sci Rep. 2024. PMID: 39488631 Free PMC article.
Glepaglutide, a Long-acting Glucagon-like Peptide-2 Analog, Reduces Parenteral Support in Patients with Short Bowel Syndrome: a Phase 3, Randomized, Controlled Trial.
Jeppesen PB, Vanuytsel T, Subramanian S, Joly F, Wanten G, Lamprecht G, Kunecki M, Rahman F, Nielsen TSS, Berner-Hansen M, Pape UF, Mercer DF. Jeppesen PB, et al. Among authors: vanuytsel t. Gastroenterology. 2024 Dec 19:S0016-5085(24)05787-1. doi: 10.1053/j.gastro.2024.11.023. Online ahead of print. Gastroenterology. 2024. PMID: 39708985 Free article.
Real-world experience with glucagon-like peptide 2 analogues in patients with short bowel syndrome and chronic intestinal failure: Results from an international survey in expert intestinal failure centers.
Vanuytsel T, Lakananurak N, Greif S, Wall E, Catron H, Herlitz J, Moccia L, Kumpf V, Mercer D, Berner-Hansen M, Gramlich L. Vanuytsel T, et al. Clin Nutr ESPEN. 2024 Dec;64:496-502. doi: 10.1016/j.clnesp.2024.10.161. Epub 2024 Nov 1. Clin Nutr ESPEN. 2024. PMID: 39489296 Free article.
Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon-in-continuity: A multicenter, open-label, metabolic balance study.
Verbiest A, Hvistendahl MK, Bolognani F, Li C, Youssef NN, Huh S, Menys A, Bhatnagar G, Vanslembrouck R, Peeters R, Sartoris R, Vermeersch P, Wauters L, Verbeke K, Jeppesen PB, Joly F, Vanuytsel T. Verbiest A, et al. Among authors: vanuytsel t. Clin Nutr. 2024 Dec;43(12):158-166. doi: 10.1016/j.clnu.2024.10.011. Epub 2024 Oct 16. Clin Nutr. 2024. PMID: 39461299 Free article. Clinical Trial.
238 results